Actually, after activation, NK cells produce cDC1 chemoattractants and secrete them into the tumor microenvironment to attract cDC1s, and thereafter cDC1s can recruit CTLs and, in turn, elicit an adaptive immune response [137]. The gene discussed is MPPE1; the disease is neoplasm.